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1. Introduction 
Plant lectins bind to glycoproteins and glycolipids 
of cell membranes and initiate a broad spectrum of 
biological and morphological responses [l-3]. Con A, 
a lectin derived from the jackbean, has been shown 
to bind glycoproteins with a high specificity for gluco- 
and mannopyranosides. This binding leads to cell 
agglutination, changes in mobility of immunoglobulin 
receptors on lymphocytes, inhibition of phagocytosis 
by polymorphonuclear leukocytes, and stimulation of 
DNA synthesis [3-6]. In addition, con A binding to 
adipocytes has been shown to mimic a variety of insu- 
lin effects [7-121. Con A has 4 sugar binding sites, 
and studies using several chemical derivatives of con A 
have suggested that many of its biological activities on 
lymphocytes are dependent upon its multivalent bind- 
ing [3,13-161. Furthermore, studies with agents 
which disrupt microtubules have suggested that stim- 
ulation of some of these effects also requires an intact 
cytoskeletal system [6,17]. Here, we have defined the 
roles of ligand valence and an intact cytoskeleton in 
the insulin-like action of con A. 
2. Materials and methods 
2 .l . Materials 
Porcine insulin (lot 7GUHSL) was purchased from 
Elanco, bovine serum albumin (fractionv, lot N53309) 
from Armour, and crude collagenase (CLS45K137) 
from Worthington Biochemicals. Cytochalasins B and 
D and colchicine were purchased from Aldrich Chem- 
Abbreviations: con A, concanavalin A; ATPase, adenosine tri- 
phosphatase 
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icals, vincristine and vinblastine from Eli Lilly, and 
dinonylphthalate from Eastman Chemicals. “%Labeled 
insulin (‘2SI-insulin) was prepared by a modification of 
the chloramine-T method at spec. act. 100-200 pCi/ 
Pi? [la. 
Con A and its derivatives were obtained from a 
variety of sources, and all lots provided consistent 
results. Con A itself was purchased from Miles Labs, 
Pharmacia Chemicals and Polysciences (Warrington 
PA). Succinyl-Con A was purchased from Polysciences, 
and was received as a kind gift from Dr G. Edelman 
(New York). Acetyl-Con A was also obtained from 
Dr Edelman. Monovalent con A produced by proteol- 
ytic digestion [ 151 was a generous gift of Dr J. R. 
Wands, Boston. 
2.2. Binding studies and glucose oxidation bioassay 
Isolated adipocytes were prepared from epididymal 
fat pads of 100-l 80 g Sprague-Dawley rats by colla- 
genase digestion [ 181. Unless otherwise noted, all 
studies of 12sI-insulin binding were performed in Krebs- 
Ringer bicarbonate buffer with albumin (PH 7.4) at 
37’C as in [ 181. ‘Nonspecific’ binding, determined as 
that amount of tracer bound in the presence of a 
1 06-fold excess of unlabeled insulin has been subtracted 
from all data to yield ‘specific’ binding. Glucose oxi- 
dation was studied by measuring the conversion of 
[U-14C]glucose to 14C02 [ 181 with an incubation 
period of 60 min. All glucose oxidation assays w&e 
performed in triplicate. 
3. Results 
As reported in [7,8], con A stimulated glucose oxi- 
dation in isolated rat adipocytes (fig.1). This effect 
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Fig.1. Effect of insulin, con A, and con A derivatives on glu- 
cose oxidation by isolated rat adipocytes. Isolated adipocytes 
were prepared and glucose oxidation studied as in section 2. 
The data shown represent the mean f SEM for triplicate 
samples. 
was observed at as low as 1 pg/ml, and increased there- 
after in a dose-dependent manner, reaching a maxi- 
mum at 100 pg/ml. In contrast to the mitogenic effect 
of con A [ 16 1, at no concentration of con A did this 
effect diminish. Compared to insulin, the normal hor- 
monal stimulator of glucose metabolism in adipose 
tissue, con A was -loo-fold less potent on a molar 
basis. Maximal stimulation of glucose oxidation by 
con A, however, was consistently 50-60s higher than 
that produced by insulin (fig.1). 
Native con A is a tetravalent tetramer [ 131; to eval- 
uate the role of valence, both bivalent and monoval- 
ent con A analogues were studied. The bivalent deriv- 
atives, succinyl- and acetylcon A which differ greatly 
in charge [3,13], both stimulated glucose oxidation 
with equipotency, but were -10% as active as native 
con A (lig.1). In contrast, monovalent con A was 
totally without effect, even at the highest concentra- 
tion tested (100 pg/ml). 
In an attempt to better understand the mechanism 
of con A stimulation of glucose metabolism, several 
additional experiments were performed. Since it has 
been suggested that the insulin-like effect of con A is 
due to binding to the insulin receptor [8], the effects 
of all derivatives on “‘I-insulin binding to adipocytes 
were examined. Under the conditions of our experi- 
ments which closely mimic those of the glucose oxi- 
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Fig.2. Effect of con A and its derivatives on ‘*51-insulin bind- 
ing to adipocytes. ‘Z51-Insulin binding to adipocytes was mea- 
sured as in section 2. The unlabeled insulin and the con A 
derivatives were added at the indicated concentrations to the 
incubation buffer containing the ‘*51-insulin (0.2 rig/ml), after 
which the suspension of adipocytes was added to give a fimal 
cell concentration of -2 x lO’/ml. Non-specific binding 
defined as the binding of ‘2sI-insulin observed in the 10 pg/ml 
has been subtracted from each point. 
dation assay, neither con A nor any of its derivatives 
produced systematic inhibition of ‘% I-insulin binding, 
even at up to 30 I.cg/ml (fig.2). Thus, the difference in 
activity of the different con A derivatives cannot be 
explained by a difference in the ability of these to 
interact with the binding site of the insulin receptor. 
A second possibility is tha’t the interactions of the 
different ligands with the cytoskeletal system of the 
cell allowed for different biological potencies. A pos- 
sible role of microtubules and microfiaments in the 
actions of both con A and insulin has been suggested 
by studies using the various agents which alter these 
structures [6,17,19]. Pretreatment of the adipocytes 
with colchicine , vincristine , and vinblastine , agents 
which alter microtubular function [20], at 10 PM, 
had no effect on basal, insulin-stimulated, or con A- 
stimulated glucose oxidation (table 1). As noted, cyto- 
chalasin B, an agent which disrupts microfilaments 
and interferes with ac tin polymerization [ 2 11, directly 
inhibits glucose transport and oxidation [22]. Despite 
this, stimulation by both con A and insulin was still 
observed, although the absolute rates of glucose 
metabolism were decreased at the higher concentra- 
tion of drug (10 gg/ml). Cytochalasin D, which also 
disrupts microfilaments and has little direct effect on 
glucose transport [ 221, produced minimal inhibition 
of basal, insulin-stimulated or con A-stimulated glu- 
cose oxidation (table 1). 
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Table 1 
Effects of anti-microtubule and anti-microfiiment agents on insulin- and con A-stimulated 
glucose oxidation 
Expt. Addition 14 CO, produced (cpm/h incubation) &mu&d/Basal 
Basal Insulin Con A Insulin Con A 
(1 .O ndml) (1 &ml) 
I None 101 f 8 74’5 * 47 649 + 28 7.4 6.4 
Colchicine 10 PM 98 f 10 649 + 41 686 + 44 6.5 7.0 
VinbIastine 10 PM 92t 4 636 f 63 593 f 40 6.9 5.9 
Vincristine 10 PM 97% 5 670 f 38 597 + 7 6.9 6.2 
II None 295 f 23 1732k 196 1581+ 77 5.9 5.4 
Cytochalasin B 
1 hdml 19t 2 143 + 20 125 + 10 7.5 6.6 
10 kdml 6+ 3 14* 5 16 f 2 2.3 2.7 
Cytochalasin D 
1 ~~g/ml 240+ 7 1445 zt 73 1441 + 69 6.0 6.0 
10 ~g/ml 189 * 10 1377 f 179 1290 * 210 7.3 6.8 
June 1981 
4. Discussion 
Con A binds to cell surface glycoproteins, glycolip- 
ids and polysaccharides; and, depending on the cell 
type, this interaction produces a wide variety of biol- 
ogical andmorphological responses [l-3]. The actions 
of con A have been most extensively studied in lym- 
phocytes [3-6,16], however, con A also has been 
shown to bind to and/or have effects on many other 
tissues. In the adipocyte, con A has been found to 
mimic many of the actions of insulin including stimu- 
lation of glucose transport and metabolism, inhibition 
of lipolysis and adenylate cyclase, stimulation of lipo- 
genesis and pyruvate dehydrogenase and stimulation of 
glycogen synthase and magnesium ATPase [7-l 2,241. 
There is considerable evidence that the stimulation 
of lymphoid cells by con A requires cross-linkage of 
cell-surface glycoprotein receptors [6,16]. Native 
con A at pH 7 is a tetramer with 4 saccharide bind- 
ing sites [3 ,131. Derivatives which are dimeric and 
divalent can be prepared by both succinylation and 
acetylation [ 131, and monovalent derivatives have 
been prepared by either proteolytic treatment [IS] or 
a combination of succinylation and photoaffinity 
labeling [ 131. These derivatives retain their carbohy- 
drate binding specificity but show a marked alteration 
in biological action on lymphocytes [3,13-l 51. Thus, 
compared to native con A, the dimeric derivatives 
show weak agglutination properties, inability to cap 
glycoprotein receptors on cells, and failure to inhibit 
Ig receptor cap formation; mitogenic activity, how- 
ever, is retained [ 141. Monovalent con A preparations 
show variable properties depending on the method of 
preparation [13-l 51. 
The cytoskeletal system also appears to play a role 
in a number of con A effects. Drugs which disrupt 
microtubules such as colchicine, vincristine and vin- 
blastine have been shown to inhibit the mitogenic 
response to con A [6,16], as well as effects of succinyl- 
con A on glial cells in tissue culture [ 171. In addition, 
intracellular membrane-associated actin is accumulated 
into patches located directly under the receptor 
patches when HeIa cells are treated with con A [23]. 
Here we have characterized the role of both recep- 
tor aggregation and the cytoskeleton in the insulin- 
like effect of con A. We find that, as with the mito- 
genie effect, the insulin-like effect of con A in adipo- 
cytes is dependent on ligand valence. Divalent deriva- 
tives of con A such as acetyl- and succinyl-con A are 
only -10% as potent as native con A in this action, 
and monovalent con A is totally without effect’. How- 
ever, in contrast to observations on the mitogenic 
action, the insulin-like effect of con A is not blocked 
by any of the agents which disrupt microtubules, 
microfilaments or alter actin polymerization [ 20-221. 
These data may have relevance not only to the 
mechanism of action of con A, but also to the mech- 
anism of insulin action. It is generally believed that 
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con A exerts its insulin-like effect by binding to the 
insulin receptor [8]. Monovalent antibodies to the 
insulin receptor, which block insulin action, partially 
inhibit theinsulin-like effect of con A [25]. Con A has 
also been shown to bind to solubilized insulin recep- 
tors and this property has proven useful for receptor 
purification [2,8]. The interaction of con A with the 
receptor, however, does not appear to occur at the 
insulin-binding site, since in most cases binding of 
‘251-insulin is not reduced ([26]; this study]. De Meyts 
[26] has suggested that con A may bind to the site on 
the receptor important for negative cooperativity, 
since con A treatment has been shown to block the 
acceleration of dissociation of ‘B I-insulin from its 
receptor produced by addition of unlabelled insulin 
(negative cooperativity). 
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